Biocon, Mylan drug discovery programme makes progress
Biocon shares were trading at Rs 425.90 apiece, up 0.16%, on the BSE.
May 07, 2015, 14:01 PM IST
Wockhardt drug discovery gets fast track approval by USFDA
This is the first instance of an Indian pharmaceutical company receiving a QIDP status, Wockhardt said in a release issued here.
Sep 01, 2014, 08:16 AM IST